Intended for UK HCPs and ORDMs only.

Atorvastatin

NICE Recommends atorvastatin¹

In 2022 it was prescribed over 57 million times in England alone²

Of 5 statins available in the UK³, it is the most widely prescribed²

Leading 10 lipid-regulating drugs dispensed in England in 2022 by number of items

Atorvastatin (57,050,843)

Simvastatin (16,016,497)

Rosuvastatin Calcium (3,688,632)

Ezetimibe (2,376,556)

Pravastatin Sodium (2,327,670)

Fenofibrate (578,424)

Bezafibrate (341,313)

Colesevelam Hydrochloride (181,467)

Colestyramine (143,074)

Fluvastatin Sodium (94,888)

Adapted from 2

In 2020, an estimated 100 million people in the USA took atorvastatin⁴

Atorvastatin is an HMG-CoA Reductase Inhibitor⁵

Illustration of liver showing how statins block progression between stage 1 and 2

Leading to deposition in blood vessels

Adapted from 6

Highly effective and shown to reduce levels of LDL by 40-60%⁷

Over 25 year track record⁵ and generally well tolerated⁸

*As an adjunct to diet and lifestyle

Atorvastatin

NICE Recommends atorvastatin¹

In 2022 it was prescribed over 57 million times in England alone²

Of 5 statins available in the UK³, it is the most widely prescribed²

Leading 10 lipid-regulating drugs dispensed in England in 2022 by number of items

In 2020, an estimated 100 million people in the USA took atorvastatin⁴

Atorvastatin is an HMG-CoA Reductase Inhibitor⁵

Illustration of liver showing how statins block progression between stage 1 and 2

Highly effective and shown to reduce levels of LDL by 40-60%⁷

Over 25 year track record⁵ and generally well tolerated⁸

References

Prescribing Information

Reporting of suspected adverse reactions

Atorvastatin

NICE Recommends atorvastatin1

In 2022 it was prescribed over 57 million times in England alone2

Of 5 statins available in the UK3, it is the most widely prescribed2

Leading 10 lipid-regulating drugs dispensed in England in 2022 by number of items

In 2020, an estimated 100 million people in the USA took atorvastatin4

Atorvastatin is an HMG-CoA Reductase Inhibitor5

Illustration of liver showing how statins block progression between stage 1 and 2

Highly effective and shown to reduce levels of LDL by 40-60%7

Over 25 year track record5 and generally well tolerated8

References

Prescribing Information

Reporting of suspected adverse reactions

NICE Recommends atorvastatin¹

In 2022 it was prescribed over 57 million times in England alone²

Of 5 statins available in the UK³, it is the most widely prescribed²

In 2020, an estimated 100 million people in the USA took atorvastatin⁴

Atorvastatin is an HMG-CoA Reductase Inhibitor⁵

Highly effective and shown to reduce levels of LDL by 40-60%⁷

Over 25 year track record⁵ and generally well tolerated⁸